Henry M. Lemon Short Course in Cancer Biology
The 2024 course is scheduled for June 27-28 and will focus on Cancer Glycoimmunology.
This annual course brings together leading scientists to address important topics in cancer research. The course will be held in the Yanney Conference Center of the Fred & Pamela Buffett Cancer Center, Room 0.12.101.Featured Speakers
Hans Wandall, MD, PhD
Professor
Department of Cellular and Molecular Medicine,
Faculty of Health Sciences
University of Copenhagen
Thursday morning lectures:
- Overview and Recent Advancement in Glycans-specific Targeted Immunotherapy in Cancer.
- Targeting of Short Cancer-Associated O-GalNAc Glycans.
Richard Cummings, PhD
S. Daniel Abraham Professor of Surgery
in the Field of Nutrition Medicine
Beth Israel Deaconess Medical Center
Boston, Mass.
Thursday afternoon lectures:
- Altered Protein Glycosylation in Cancer.
- Alterations in O-Glycosylation of Glycoproteins in Human Carcinomas.
Yvette van Kooyk, PhD
Professor
Department Molecular Cell Biology, and Immunology
Amsterdam UMC
Vrije Universiteit Amsterdam
Friday morning lectures:
- Recent Advances of Glycoimmunology in the Cancer Immunity Cycle.
-
The Role of the Tumor Glyco-Code as Immune Checkpoint.
Susan Bellis, PhD
Professor of cell, developmental and integrative biology
University of Alabama at Birmingham
Friday afternoon lectures:
- Regulation of Tumor Immunity by Sialylated Glycans.
-
Role of Tumor Glycans in Pancreatic Cancer Progression and Immunosuppression.
2024 Faculty Host
About Henry M. Lemon
After graduating cum laude from Harvard Medical School in 1940, Dr. Henry Lemon held positions at the University of Chicago Clinics and Boston University School of Medicine before being appointed the first director of the Eugene C. Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center (UNMC). He served as director of the institute from 1961 to 1968. He was a professor of Internal Medicine, and served as the Assistant Dean, Research Affairs at UNMC from 1961-1965.
Dr. Lemon was instrumental in establishing UNMC as a major cancer research and treatment center. He warned of the cancer-causing effects of cigarette smoking in the mid 1960s, developed better methods of administering chemotherapy and contributed to a program that improved the teaching of cancer in medical schools. Dr. Lemon’s research focused on estrogen metabolism and breast cancer.
Dr. Lemon trained numerous students and fellows in his laboratories in both Boston and Omaha, and was author or co-author of over 170 publications during his career. He died in 1997.